期刊文献+

5-甲基-1,2,4-三唑-3-硫酮类糖苷化合物的合成及抗菌活性 被引量:5

Synthesis and Antibacterial Activities of 5-Methyl-1,2,4-triazole-3-thione Glucosides Compounds
下载PDF
导出
摘要 在KOH/丙酮体系中,以5-甲基-4-N-取代苯基亚胺/胺基-1,2,4-三唑-3-硫酮为原料,与溴-α-D-四乙酰葡萄糖进行Kenigs-Knorr反应合成了10个新颖的化合物——5-甲基-4-N-取代苯基亚胺基/胺基-3-S-(2',3',4',6'-四-O-乙酰基-β-D-吡喃葡萄糖基)-1,2,4-三唑(2a^2e,5a^5e);并在二氯甲烷/甲醇/甲醇钠混合体系中水解脱除乙酰基,得到10个新颖的化合物——5-甲基-4-N-取代苯基亚胺基-3-S-(β-D-吡喃葡萄糖基)-1,2,4-三唑(3a^3e)及5-甲基-4-N-取代苯基胺基-3-S-(β-D-吡喃葡萄糖基)-1,2,4-三唑(6a^6e).化合物的结构均经核磁共振波谱(NMR)、红外光谱(IR)和高分辨质谱(HRMS)分析确证.生物活性测试结果表明,目标化合物对大肠杆菌、金黄色葡萄球菌、枯草芽孢杆菌和白色念珠球菌普遍具有较好的抗菌活性.化合物3d和3e对4种菌株的最小抑菌浓度相对较低,表现出较强的广谱抗菌活性. Ten novel compounds of 5-methy-4- ( N-substituted-phenyl ) imino/amido-3-S- ( 2', 3', 4', 6 '-tetra-O-acetyl-β-D-glucopyranoside ) -1 5 -methy-4- ( N-substituted-phe ,2,4-triazole (2a-2e and 5a-5e ) were synthesized via glycosylation of ) imino/amido-1,2,4-triazole-3-thiones with bromo-2,3,4,6-tetra-O-acetyl- β-D-glucopyranoside in acetone in the presence of potassium hydroxide. Subsequently, ten novel compounds of 5-methy-4- ( N-substituted-phenyl ) imino/amido-3-S- (β-D-Glucopyranosyl) -1,2,4-triazole ( 3a-3e and 6a- 6e) were generated by deacetylate reaction in the system of sodium methylate, methanol and dichloromethane. The structures of all compounds were confirmed by ^1H NMR, ^13C NMR, IR and HRMS spectra. The results of preliminary bioassay suggested that nearly all of the new compounds exerted variable inhibitory activity against Escherichia coli, Staphylococcus aureus, Bacillus subtilis and Monilia albican. Especially, compounds 3d and 3e had lower minimum inhibitory concentration values on four tested strains which showed the strong broadspectrum antimicrobial activity and great development potential.
出处 《高等学校化学学报》 SCIE EI CAS CSCD 北大核心 2016年第2期246-253,共8页 Chemical Journal of Chinese Universities
基金 国家自然科学基金(批准号:21176194 21476174)资助~~
关键词 5-甲基-4-N-取代苯基亚胺/胺基-1 2 4-三唑-3-硫酮 S-β-D-糖苷 抗菌活性 5-Methy-4- ( N-substituted-phenyl ) imino/amido-1, 2, 4-triazole-3-thione S-β-D-Glucoside Antibacterial activity
  • 相关文献

参考文献7

二级参考文献114

  • 1张奎,许燕红.抗肿瘤药氟达拉滨的合成[J].精细化工中间体,2004,24(4):33-35. 被引量:5
  • 2于华生,郑一赛,陈婕.HPLC-ELSD法测定硫酸西索米星氯化钠注射液中西索米星含量[J].海峡药学,2004,16(6):41-43. 被引量:9
  • 3刘耀文.以钠-葡萄糖同向转运体为靶标的糖尿病治疗药物[J].国外医学(药学分册),2005,32(2):109-111. 被引量:7
  • 4王增霞,周善学.新型氨基糖苷类抗生素合成的最新进展[J].国外医药(抗生素分册),2007,28(4):155-166. 被引量:9
  • 5Gerard D Wrigh, Paul R Thompson. Aminoglycoside phosphotransferases : proteins, structure, and mechanism [ J ]. Frontiers in Bioscience,1999,1 (4) :9.
  • 6Emily Jin, Vsevolod Katritch, Wilma K Olson, et al. Aminoglycoside binding in the major groove of duplex RNA: the thermodynamic and electrostatic forces that govern recognition [ J ]. Journal of Molecular Biology,2000, 298 ( 1 ) :95.
  • 7Barluenga S, Simonsen KB, Littlefield ES, et al. Rational design of azepane-glycoside antibiotics targeting the bacterial ribosome [ J ]. Bioorganic & medicinal chemistry letters,2004,14 (3) :713.
  • 8Green Michael R, Zapp Maria L, Stern Seth. 2-deoxystreptamine aminoglyeoside inhibition of HIV RRE/Rev binding [ P ]. United States Patent, 5534408,1996-07-09.
  • 9Serena Bemacchi ,Severine Freisz ,Clarisse Maechling,et al. Aminoglycoside binding to the HIV-1 RNA dimerization initiation site: thermodynamics and effect on the kissing-loop to duplex conversion[J]. Nucleic Acids Research,2007, 35(21 ) :7128.
  • 10Alexandr Nemec, LucillaDolzani, Sylvain Brisse, et al. Diversity of aminoglycoside-resistance genes and their association with class 1 integrons among strains of pan-European Acinetobacter baumannii clones [ J ]. Journal of Medical Microbiology,2004,53 ( 12 ) : 1233.

共引文献40

同被引文献54

  • 1李鸣建,冯惠,冯长君,杨伟华.取代喹啉类化合物抗菌活性的3D-QSAR研究及分子设计[J].化学通报,2015,78(2):153-157. 被引量:4
  • 2Mai A. , Chem. Med. Chem. , 2014, 9(3) , 415-417.
  • 3Arrowsmith C. H. , Bountra C. , Fish P. V. , Lee K. , Schapira M. , Nat. Rev. Drug. Discov. , 2012, 11(5) , 384-400.
  • 4Dhanak D. , Jackson P. , Biochem. Biophys. Res. Commun. , 2014, 455, 58-69.
  • 5Owen D. R. , Trzupek J. D. , Drug. Discov. Today Technol. , 2014, 12, e29-e34.
  • 6Herold J. M., Ingerman L. A., Gao C., Frye S. V., Curr. Chem. Genomics, 2011, 5, 51-61.
  • 7James L. I. , Frye S. V. , Clin. Pharmacol. Ther. , 2013, 93(4) , 312-314.
  • 8Kalakonda N. , Fisehle W. , Boccuni P. , Gurvich N. , Hoya-Arias R. , Zhao X. , Miyata Y. , Macgrogan D. , Zhang J. , Sims J. K. Rice J. C. , Nimer S. D. , Oncogene, 2008, 27(31) , 4293-4304.
  • 9Trojer P. , Li G. H. , Sims R. J. , Vaquero A. , Kalakonda N. , Boccuni P. , Lee D. , Erdjument-Bromage H. , Tempst P. , Nimer S D. , Wang Y. H. , Reinberg D. , Cell, 2007, 129(5) , 915-928.
  • 10West L. E. , Roy S. , Lachmi-Weiner K. , Hayashi R. , Shi X. B. , Appella E. , Kutateladze T. G. , Gozani O. , J. Biol. Chem. , 2010, 285(48), 37725-37732.

引证文献5

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部